Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Accelerate Diagnostics 4.94 -0.06 -1.20% -36.18%
Natus Medical 22.39 -0.21 -0.93% 6.16%
Bruker 81.01 0.02 0.02% 56.63%
Computer Programs Systems 29.72 0.25 0.85% 6.18%
Plus Therapeutics, Inc. 1.38 -0.12 -8.00% -33.01%
Quest Diagnostics 151.24 2.56 1.72% 21.60%
EDAP TMS 5.73 0.02 0.35% 42.54%
Fluidigm 4.41 -0.20 -4.34% -27.23%
GenMark Diagnostics 24.04 0 0% 169.66%
Hologic 73.06 -1.67 -2.23% 3.10%
Illumina 357.66 -7.67 -2.10% 4.94%
Laboratory Of America 285.45 0.12 0.04% 43.56%
Luminex 36.99 0 0% 10.02%
Myriad Genetics 24.90 -0.96 -3.71% 34.38%
Oxford Immunotec Global 21.95 -0.04 -0.18% 80.07%
Pacific Biosciences Of California 21.14 -2.07 -8.92% 17.44%
Quidel 144.69 -2.87 -1.95% -27.28%
Sientra 3.83 -0.19 -4.73% -24.01%
Thermo Fisher Scientific 626.15 -6.68 -1.06% 30.75%
Trinity Biotech 1.80 -0.05 -2.70% -60.26%
Veracyte 37.92 -3.56 -8.58% -31.15%
Waters 328.50 0.43 0.13% 39.72%

Indexes Price Day Year
US2000 2147 -51.49 -2.34% 16.83%
NASDAQ 15254 -283.64 -1.83% 23.52%

Oxford Immunotec Global
Oxford Immunotec Global PLC is a global, commercial-stage diagnostics company. The Companys T-SPOT technology platform allows the Company to measure the responses of specific immune cells, known as T cells, to inform the diagnosis, prognosis and monitoring of patients with immunologically controlled diseases. T cells are a central component of the human bodys immune system, and are implicated in the control and progression of many medical conditions, including certain types of infectious diseases, cancers and autoimmune diseases. The initial product it has developed using its T-SPOT technology platform is its T-SPOT.TB test, which is used to test for latent Tuberculosis (TB) infection (LTBI). In August 2014, the Company acquired Boulder Diagnostics Inc.